Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to ovarian cancer. Additionally, several specific cancer types and drug categories have been removed.
    Difference
    9%
    Check dated 2025-08-31T01:06:17.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated with new dates for events, specifically adding '2025-06-01', '2025-08-18', and '2025-08-22', while removing previous dates including '2024-11-07' and '2024-11-06'. Additionally, significant contact information for multiple study contacts and principal investigators has been removed.
    Difference
    5%
    Check dated 2025-08-23T21:56:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T19:59:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-09T15:09:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T13:59:13.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-26T12:12:56.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.